Bio-Path Holdings, Inc. (BPTH) Reports Second Quarter 2013 Operational and Financial Results
8/15/2013 8:04:52 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Bio-Path Holdings, Inc., (OTCQX: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the second quarter ended June 30, 2013.
Hey, check out all the research scientist jobs. Post your resume today!